ENLIVEX THERAP.LTD.IS-,01/ IL0011319527 /
| 5/27/2024 8:05:29 AM | Chg. +0.0200 | Volume | Bid8:05:31 AM | Ask8:05:31 AM | High | Low |
|---|---|---|---|---|---|---|
| 1.2700EUR | +1.60% | 0 Turnover: 0.0000 |
1.2700Bid Size: 1,595 | 1.3200Ask Size: 1,520 | 1.2700 | 1.2700 |
GlobeNewswire
4/22
Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evalua...
GlobeNewswire
4/16
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Cont...
GlobeNewswire
4/11
Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from...
GlobeNewswire
4/11
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsi...
GlobeNewswire
2/7
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Metho...
GlobeNewswire
12/20/2023
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients Wi...
GlobeNewswire
9/11/2023
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
GlobeNewswire
9/7/2023
Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
3/8/2022
Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
GlobeNewswire
2/22/2022
Enlivex Strengthens Management Team with the Appointment of Biotech Industry Veteran Einat Galamidi,...
GlobeNewswire
1/3/2022
Enlivex to Detail the Application of its Innovative Macrophage Reprogramming Cell Therapy to Unmet N...
GlobeNewswire
12/13/2021
Enlivex Receives Regulatory Authorization to Expand its Phase IIb Trial Evaluating Allocetra in Seve...
GlobeNewswire
12/7/2021
Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece
GlobeNewswire
12/6/2021
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Treatment of Sepsis Pa...
GlobeNewswire
11/22/2021
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update
GlobeNewswire
11/10/2021
Spanish Regulator Grants Enlivex Authorization to Expand its Phase IIb Trial Evaluating Allocetra in...
GlobeNewswire
11/4/2021
Spanish Regulator Grants Enlivex Authorization To Expand Its Sepsis Phase II into Spain
GlobeNewswire
10/12/2021
Enlivex CSO Prof. Dror Mevorach Publishes Foundational Paper on the Pfizer–BioNTech COVID-19 Vaccin...
GlobeNewswire
10/5/2021
Enlivex Receives Notice of Allowance for Israeli Patent Application Covering Allocetra Derived from ...
GlobeNewswire
10/4/2021
Enlivex Announces the Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data from Pha...
GlobeNewswire
9/22/2021
Enlivex Doses First Patient in Placebo-Controlled Phase IIb Clinical Trial Evaluating Allocetra in S...
GlobeNewswire
9/9/2021
Enlivex to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
